Trending News
News
News
Mechanism of Action of ABIVAX’s First-in-class Anti-HIV Drug Published
Novel mechanism of action - prevention of viral RNA exit from nucleus of infected cells - associated to unique anti-viral properties.
News
Drug Target for ATRA Identified
Discovery offers a new way to fight cancer by targeting the Pin1 enzyme.
News
Optibrium and ChemAxon Collaborate
Interface between StarDrop and Plexus facilitates seamless access to both software platforms.
News
Recipharm Makes Strategic Investment in Synthonics
Recipharm has purchased $2.0 million of preferred stock in the company.
News
The First Emerald Cloud Lab Production Facility Unveiled
“Cloud Lab” changes game for researchers with online access to state-of-the-art robotic lab equipment.
News
Global Flow Chemistry Market 2014-2020
Key vendors are Syrris, ThalesNano, Uniqsis, Vapourtec, FutureChemistry, Chemtrix, AM Technology, Royal DSM and Lonza.
News
Novel Ultra-Low Temperature Microreactor Chips
Syrris has launched ultra-low temperature 3-input microreactor chips.
News
Cipher Acquires INNOCUTIS Holdings, Licensee of Sitavig® in the USA
Acquisition will further strengthen Sitavig®'s position.
News
Medivir and Cancer Research Technology Collaborate
Collaboration will lead to development of new class of cancer drugs.
News
ThromboGenics and VIB Launch New Oncology Company
Oncurious NV to develop TB-403 for pediatric brain tumors.
Advertisement